|The Center for Practice Innovation's (CPI) primary goals are to promote the widespread availability of mental health evidence-based practices in New York State, promote innovations related to emerging promising practices, cultural adaptations and organizational change approaches and to create informational and educational resources for the general public as well as users and providers of mental health services.|
Easy Link to Considering Clozapine Module for Consumers Now Available
In partnership with the New York State Office of Mental Health (OMH), the Center for Practice Innovations (CPI) is pleased to announce the publicly-available interactive educational program "Considering Clozapine" on CPI's website.
Clozapine remains the most effective antipsychotic for individuals with schizophrenia and schizoaffective disorder who have not responded to other medications. Developed for individuals who have these diagnoses, Considering Clozapine helps people prepare to talk with their prescriber about whether clozapine may be right for them.
Click here to see Considering Clozapine.
If you would like to read more about Considering Clozapine, please click here.